Gene Delivery Platform for the Prevention and Treatment of Hair Loss (Gene Delivery for Prevention and Treatment of Baldness, Tech ID: 23‑008)
Technology Overview: This technology provides a gene delivery platform targeting hair follicles to address hair loss conditions such as androgenetic alopecia. The system enables localized delivery of genetic material that modulates biological pathways associated with hair growth and follicle regeneration. By targeting the root biological causes of hair loss, this approach offers a potential long‑term alternative to topical or pharmaceutical treatments.
Industry Pain Point: Current hair loss treatments provide limited efficacy and require continuous use.
NJIT Solution: This platform enables localized gene‑based intervention to promote sustained hair regeneration.
Key Features & Advantages
- Targeted gene delivery to hair follicles
- Potential for long‑lasting therapeutic effects
- Reduced systemic exposure
- Adaptable gene therapy platform
Development Stage: TRL 2–3 – Early‑stage concept and preclinical validation.
Target Markets
- Hair restoration therapeutics
- Dermatology and aesthetic medicine
- Gene‑based cosmetic treatments
Market Opportunity
- Global hair loss treatment market (2026): ~$6B
- CAGR: ~7–8%
- Projected market size (2035): ~$11–12B
Commercial & IP Details
Inventors: William Ho, Zhongyu Li, Xiaoyang Xu